Global Search
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Abstracts & Posters

Genome Editing in Mucopolysaccharidoses and Mucolipidoses

key information

source: Progress in Molecular Biology and Translational Science

year: 2021

authors: Santos HS,Poletto E,Schuh R,Matte U,Baldo G

summary/abstract:

Mucopolysaccharidoses (MPS) and mucolipidoses (ML) are disorders that alter lysosome function. While MPS are caused by mutation in enzymes that degrade glycosaminoglycans, the ML are disorders characterized by reduced function in the phosphotransferase enzyme. Multiple clinical features are associated with these diseases and the exact mechanisms that could explain such different clinical manifestations in patients are still unknown. Furthermore, there are no curative treatment for any of MPS and ML conditions so far. Gene editing holds promise as a tool for the creation of cell and animal models to help explain disease pathogenesis, as well as a platform for gene therapy. In this chapter, we discuss the main studies involving genome editing for MPS and the prospect applications for ML.

organization: Laboratório Células, Tecidos e Genes do Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.

DOI: 10.1016/bs.pmbts.2021.01.026

read more

Related Content

© 2023 rareLife solutions Inc.